Jordana Joy, Associate Editor

Ashley Mills, The Vision Council CEO, outlines new additions to the show that are unveiling what is to come in terms of fashion, technology, and patient care.

Catch up on the top stories in optometry during the week of February 10-February 14.

According to a news release from the company, the VR platform “disrupt[s] traditional diagnostic methods by offering an untethered, all-in-one diagnostic solution that includes a variety of tests such as visual field, progression analysis, color sensitivity, and now visual acuity testing.”

The Vision Council CEO Ashley Mills overviews what is new and exciting at this year's show, running from February 19-22 in Orlando, Florida, and provides a free registration code for those still looking to register.

Practice Compliance Solutions, CodeSAFEPLUS, Practice Resource Management, and EyeCode Education have formed Practice Performance Partners.

Walline, OD, PhD, FAAO, outlines how to predict myopia progression and delay its onset in an exclusive interview with Optometry Times.

Toronto-based Cellview currently designs and manufactures highly performant diagnostic imaging instruments that leverage internal R&D expertise, according to a news release.

The review “illuminates the pressing need for further research into this sight-threatening condition, particularly prospective, randomized, or well controlled cohort studies,” according to its authors.

Jeffrey Walline, OD, PhD, FAAO, overviews a presentation he gave on the Bifocal Lenses in Nearsighted Kids 2 (BLINK2) cohort study at the Collaborative Community on Ophthalmic Innovation (CCOI).

The device was created in collaboration with SlitLED and featuring AutoAquire, RemotePilot, and Multi-Slit views.

Walline, OD, PhD, FAAO, states that the best way to learn the benefits of artificial intelligence for your practice is to stay on top of continuing education attendance.

Now, the VTO platform features 3 different offerings, 2 which are new and 1 which has been updated, according to the company.

The CREST Registry study reported on the safety and effectiveness outcomes of microinvasive cyclodialysis clef formation with the CycloPen system, followed by scleral reinforcement with AlloFlo Bio-Tissue implantation, according to Iantrek.

The announcement comes after a request was made by the Canadian Investment Regulatory Organization (CIRO) to explore the possibility of a sale.

Catch up on what happened in optometry during the week of February 3-February 7.

Jeffrey Walline, OD, PhD, FAAO, gives an overview of the AAO's 2024 and what to expect in 2025 and beyond.

The Sentinel Camera aims to address critical gaps in retinal disease screening by offering a portable device that captures high-quality images that require no dilation of the eye.

The company sits at spot 43 for “its outstanding performance in areas including unit growth, financial strength and stability, and brand power."

All QLS-111 concentrations and dose regimens in both Osprey and Apteryx trials “demonstrated excellent safety and tolerability,” according to the company.

The goal of the agreement is to advance Eleva’s current programs into mid- and late-stage clinical development.

C.Rex is the only MGIS technology on the market that allows for fully titratable 180-360 comprehensive intervention.

Wells Fargo, Kirkland & Ellis, and PricewaterHouse Coopers International Limited served as main advisors to VSP Vision on the acquisition.

The partnership will allow Kendra Scott to open availability of its eye wear in the United States starting in September 2025.

The 12-year nationwide cohort found that significant differences in open angle glaucoma risk when assessing the presence of aura were not recorded between the study groups.

Catch up on what happened in optometry during the week of January 27-January 31.

Eight of this year's Visionaries are returning to the program after previous service, with the other 10 being newly appointed this year.

Study authors found that central corneal temperature could decrease faster with insufficient recovery time or severe symptoms, indicating a faster evaporation of the tear film.

The 2025 Myopia Research Grant will comprise of 3 awards of $500,000 each.

Cotter, OD, MS, FAAO, was recognized with the Optometrist of the Year Award by Universitat Politècnica de Catalunya Faculty of Optics and Optometry of Terrassa, and as the 2024 UAB School of Optometry’s Springer Lecturer.

Two posters presented research conducted on the optical design used in MyDay Energys and Biofinity Energys.